The Science & Treatment of Obsessive Compulsive Disorder (OCD) | Huberman Lab Essentials

Huberman contrasts this with standard anxiety treatments that aim to reduce anxiety (breathing, self-talk). In ERP the goal is the opposite: to let anxiety reach its maximum while preventing the usual safety behavior. The patient is not 'thrown in the deep end' — exposures are graduated hierarchically. The clinician works to pinpoint not just general obsessions but the exact catastrophic fear driving them. Huberman explains this is critical for disrupting the neural loop; by surviving the high anxiety without the compulsion, the cortex learns a new no-go rule, and thalamic gating of the fear signal changes.

Huberman frames SSRIs as a real but incomplete tool. He explains that neuroimaging shows SSRIs suppress the OCD circuit, but clinical data put them far behind CBT in magnitude of symptom reduction. He emphasizes the paradox that a drug working through serotonin can be beneficial even though serotonin dysfunction has not been proven as causal. This leads him to recommend that if a patient is on an SSRI, the ideal is to also pursue CBT, and that decisions to discontinue medication should only be done with a physician.

He makes the broader point that this pattern is not unique to OCD but is a 'consistent theme in the field of psychiatry' — drugs can be partially effective while the targeted system shows no evidence of being causally involved. He uses this to shift the listener's focus back to the cortico-striatal-thalamic circuit as the primary locus of pathology and the target that CBT directly addresses by teaching anxiety tolerance and compulsion suppression.